The appeals court questioned HHS’ authority and whether the list price would only confuse consumers.
MM&M presents its first annotated guide to the most essential DTC regulations and requirements.
Big words and warnings. Not much time. The voices behind pharma ads bring art to science.
Eli Lilly and Johnson & Johnson take the lead on PhRMA’s new guidelines for DTC ads.
Ogilvy Health’s Samantha Dolin ranks the year’s 10 best DTC campaigns. Spoiler: 60-second TV spots no longer rule the day.
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
Belle Frank is chief strategy officer, global health practice at VMLY&R.
The drugmaker will add list prices to ads for Xarelto by the end of March.
President Trump’s blueprint to lower drug prices hasn’t made it out of the brainstorm phase.
Eli Lilly is the first pharma company to react to PhRMA’s revised marketing guidelines, which go into effect in the spring.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.